Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
AIDS Care ; 30(3): 369-377, 2018 03.
Article in English | MEDLINE | ID: mdl-28859495

ABSTRACT

Economic strengthening (ES) interventions are increasingly promoted to support the economic well-being and food security of people living with HIV (PLHIV) in resource poor settings. This study aims to assess the impact of ES interventions in Ethiopia designed to address poverty and food insecurity on antiretroviral treatment (ART) adherence. A comparative cross-sectional design was employed to compare treatment adherence between food insecure PLHIV benefitting from the ES project of WFP Ethiopia to food insecure PLHIV not participating in ES. Using the visual analogue scale (VAS) to measure ART adherence, only 9.9% of the ES group reported less than 95% adherence compared to 25.9% of the comparison group. Controlling for socio-economic and demographic variables using logistic regression models, engagement in ES activities increased the likelihood of having 95% or greater ART adherence by a factor of 2.4 and 5.6 respectively (as measured by VAS and ACTG approaches) compared to those PLHIV that were not engaged in ES. The findings of the study suggest that engagement in ES contributes to improved ART adherence among food insecure PLHIV. If further studies validate this result, ES should be adopted as a key strategy to improve HIV treatment adherence in resource poor settings where adherence is an issue of concern.


Subject(s)
Anti-Retroviral Agents/therapeutic use , Food Supply , HIV Infections/drug therapy , HIV Infections/psychology , Medication Adherence/psychology , Public Assistance/economics , Adult , Anti-Retroviral Agents/economics , Cross-Sectional Studies , Economic Status , Ethiopia , Female , HIV Infections/economics , Humans , Male , Middle Aged , Treatment Adherence and Compliance , Treatment Outcome
2.
AIDS Care ; 23(2): 221-30, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21259135

ABSTRACT

This study aimed to assess the prevalence and correlates of food insecurity in a cohort of HIV-infected individuals on highly active antiretroviral therapy (HAART) in British Columbia (BC), Canada. Adults receiving HAART voluntarily enrolled into the Longitudinal Investigations into Supportive and Ancillary Health Services (LISA) cohort. Individual food insecurity was measured using a modified version of the Radimer/Cornell Questionnaire. We performed bivariate analyses to determine differences between explanatory variables for individuals who were food secure and food insecure. We performed logistic regression to determine independent predictors of food insecurity. Of the 457 individuals enrolled in the LISA cohort, 324 (71.0%) were found to be food insecure. Multivariate analysis indicated that individuals who had an annual incomes less than $15,000 (odds ratio [OR] 3.15, 95% confidence interval [CI] 1.83, 5.44), used illicit drugs (OR 1.85, 95% CI 1.03, 3.33), smoked tobacco (OR 2.30, 95% CI 1.30, 4.07), had depressive symptoms (OR 2.34, 95% CI 1.38, 3.96), and were younger (OR 0.95, 95% CI, 0.92, 0.98) were more likely to be food insecure. Our results demonstrated a high (71%) prevalence of food insecurity among HIV-infected individuals receiving HAART in this resource-rich setting, and that food insecurity is associated with a compendium of environmental and behavioral factors. More research is needed to understand the biological and social pathways linking food insecurity to these variables in order to identify program strategies that can effectively improve food security among HIV-infected populations.


Subject(s)
Antiretroviral Therapy, Highly Active , Food Supply , HIV Infections , Adult , British Columbia/epidemiology , Cross-Sectional Studies , Female , Food Supply/economics , HIV Infections/economics , HIV Infections/epidemiology , HIV Infections/therapy , Humans , Male , Middle Aged , Poverty/psychology , Prevalence , Socioeconomic Factors
3.
AIDS Care ; 18(8): 931-3, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17012082

ABSTRACT

Botswana, with its estimated HIV prevalence of 37%, instituted a policy of universal access to antiretroviral therapy (ART) in 2002. Initial enrolment lagged behind expectations, with a shortfall in voluntary testing that observers have attributed to HIV-related stigma - although there are no published data on stigma among HIV-positive individuals in Botswana. We interviewed 112 patients receiving ART in 2000, finding evidence of pervasive stigma in patterns of disclosure, social sequelae, and delays in HIV testing. Ninety-four percent of patients reported keeping their HIV status secret from their community, while 69% withheld this information even from their family. Twenty-seven percent of patients said that they feared loss of employment as a result of their HIV status. Forty percent of patients reported that they delayed getting tested for HIV; of these, 51% cited fear of a positive test result as the primary reason for delay in seeking treatment, which was often due to HIV-related stigma. These findings suggest that success of large-scale national ART programmes will require initiatives targeting stigma and its social, economic and political correlates.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/psychology , Stereotyping , Adult , Botswana/epidemiology , Female , HIV Infections/diagnosis , HIV Infections/drug therapy , Humans , Male , Middle Aged
4.
Eur J Pharmacol ; 275(1): 1-7, 1995 Feb 24.
Article in English | MEDLINE | ID: mdl-7774655

ABSTRACT

The effects of sigma ligands on turning behavior and striatal tyrosine hydroxylase activity were determined following microinjection of two chemically dissimilar sigma ligands into the rat substantia nigra. Striatal tyrosine hydroxylase activity was monitored by measuring the amount of 3,4-dihydroxyphenylalanine (DOPA) formed following inhibition of DOPA decarboxylase activity with m-hydroxybenzylhydrazine (NSD-1015). The sigma ligands, 1,3-di-o-tolylguanidine (DTG) and (-)-deoxy-N-benzylnormetazocine, produced a significant increase both in contralateral turning and in tyrosine hydroxylase activity. The DTG-induced increase in tyrosine hydroxylase activity was not antagonized by intranigral injection of the NMDA receptor antagonist, 3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid (CPP). CPP alone produced significant contralateral turning that was not accompanied by an increase in striatal tyrosine hydroxylase activity, indicating that turning per se is not sufficient to activate striatal tyrosine hydroxylase. The DTG-induced increase in tyrosine hydroxylase activity was antagonized by general anesthetics such as halothane and chloral hydrate. These results indicate that occupancy of sigma receptors in the substantia nigra is associated with an activation of dopamine formation in dopaminergic terminals in the striatum and support the concept that sigma activity in the substantia nigra produces an activation of dopamine-mediated responses in the striatum.


Subject(s)
Anticonvulsants/pharmacology , Corpus Striatum/enzymology , Guanidines/pharmacology , Receptors, sigma/metabolism , Tyrosine 3-Monooxygenase/metabolism , Animals , Aromatic Amino Acid Decarboxylase Inhibitors , Behavior, Animal/drug effects , Chromatography, High Pressure Liquid , Corpus Striatum/drug effects , Cyclazocine/analogs & derivatives , Cyclazocine/pharmacology , Dihydroxyphenylalanine/metabolism , Guanidines/administration & dosage , Hydrazines/pharmacology , Male , Microinjections , Piperazines/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, sigma/drug effects , Substantia Nigra/drug effects , Substantia Nigra/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...